TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support March 25, 1988
TCL Archive Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research March 1, 1974